Holger Moch, MD is Professor of Pathology at the University Zurich and Chairman of the Department of Pathology and Molecular Pathology, University Hospital Zurich, Switzerland since 2004. He graduated from Humboldt University Berlin (Charité), Germany and received his MD in 1988. Following graduation, he was a resident at the Institute for Pathology, Charité Berlin and at the Institute for Pathology, University Basel, Switzerland. He was a research fellow in the Division of Molecular Cytometry, Department of Laboratory Medicine, University of California San Francisco; USA and a visiting fellow at Harvard Medical School, Department of Pathology, Massachusetts General Hospital Boston, Massachusetts, USA. Since 2016, he is associate member of the Department of Biology at the Swiss Federal Institute of Technology (ETH).
Holger Moch developed a robust translational research program to understand the molecular background of urogenital tumors. His work is described in more than 500 peer-reviewed papers (H-Index 95; May 2021). He edited the 2016 WHO “blue book” World Health Organization Classification of Tumours of the Urinary System and Male Genital Organs and he is now an editorial board standing member of the WHO Classification of Tumours (5. Edition). Holger Moch is member of the German National Academy of Science Leopoldina, the Swiss Academy of Medical Sciences and the current president of the European Society of Pathology (ESP).
Updated: June 2021